Skip to Content

Notice

Importer of Controlled Substances Registration

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of registration.

SUMMARY:

Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration as importers of various classes of schedule I or II controlled substances.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.

CompanyFR DocketPublished
Almac Clinical Services Incorp (ACSI)82 FR 37114August 8, 2017.
Stepan Company82 FR 41054August 29, 2017.
Fresenius Kabi USA, LLC82 FR 41053August 29, 2017.
Cambrex Charles City82 FR 41055August 29, 2017.
Spex Certiprep Group, LLC82 FR 42120September 6, 2017.
Akorn, Inc82 FR 42117September 6, 2017.
Fisher Clinical Services, Inc82 FR 42121September 6, 2017.
Siegfried USA, LLC82 FR 42117September 6, 2017.
Mylan Pharmaceuticals, Inc82 FR 42120September 6, 2017.
KVK-Tech, Inc82 FR 42119September 6, 2017.
Cerilliant Corporation82 FR 43404September 15, 2017.
Unither Manufacturing LLC82 FR 43571September 18, 2017.
Mylan Pharmaceuticals, Inc82 FR 43572September 18, 2017.
Catalent Centers, LLC82 FR 43569September 18, 2017.
Specgx LLC82 FR 43571September 18, 2017.
Sharp Clinical Services, Inc82 FR 43572September 18, 2017.
Cody Laboratories, Inc82 FR 45612September 29, 2017.
Bellwyck Clinical Services82 FR 45613September 29, 2017.

The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons.

Start Signature

Dated: November 16, 2017.

Demetra Ashley,

Acting Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2017-25284 Filed 11-21-17; 8:45 am]

BILLING CODE 4410-09-P